Activotec announces further business expansion

09-Jan-2009 - United Kingdom

Activotec has announced a major expansion of its Cambridge, UK Headquarters and investment in new sales and production staff to meet the demand for its Activo-P11 Peptide Synthesize.

Chris Littlewood, Chief Executive of Activotec, commented "2008 peptide synthesizer sales have exceeded even our most optimistic expectations". He added "We are the only European company with international service and support teams that are exclusively focused on peptide synthesis instrumentation and services. This enables Activotec to be uniquely positioned to provide customers with informed technical assistance enabling them to get the most from their peptide synthesizer".

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances